MKI67 and neoplasm: Biological tumor markers are used as measures of clinical efficacy when evaluating novel neo-adjuvant therapies., Ki67 is a biological tumor marker that follows changes in tumor proliferation between pre- and post-therapeutical samples, typically core biopsies and surgical samples [10,26,27].